Australian Clinical Labs (ACL) is one of Australia's largest private providers of pathology services. They offer a comprehensive range of diagnostic testing services to general practitioners, medical specialists, private and public hospitals, and corporate clients. ACL is dedicated to delivering high-quality, accurate, and timely results to support patient diagnosis and treatment. Their network includes numerous NATA-accredited laboratories and approved pathology collection centres strategically located across Australia.
The headquarters serves as the central administrative and strategic command center for ACL's national operations, overseeing finance, human resources, IT, corporate strategy, and governance.
The facility likely incorporates advanced administrative offices and may be co-located with or near major laboratory operations, benefiting from its proximity to Monash University and the Monash Health precinct.
The work culture at ACL's headquarters is expected to be professional, collaborative, and focused on efficiency and precision, reflecting the critical nature of pathology services in healthcare. There's a strong emphasis on quality assurance and continuous improvement.
As the nerve center for a major national pathology provider, the headquarters plays a vital role in ensuring consistent service quality, operational excellence, and strategic growth across Australia's healthcare landscape.
Australian Clinical Labs' operations are primarily focused within Australia. They serve the Australian healthcare market with a national network of laboratories and collection centres. While they may engage with international suppliers for equipment and reagents, or participate in global research initiatives, their core service delivery and physical presence are domestic.
1868-1892 Dandenong Road
Clayton
VIC
Australia
Address: Lexington Corporate, Tenancy 301, Level 3, 24-32 Lexington Drive, Bella Vista NSW 2153
Serves as a key diagnostic centre for NSW, ensuring efficient sample processing, analysis, and result delivery to support patient care across the state.
Address: 10 King Edward Road, Osborne Park WA 6017
Acts as the central facility for diagnostic testing in WA, crucial for supporting healthcare services including those in remote and regional communities.
Address: 21 James Congdon Drive, Thebarton SA 5031
Supports the South Australian healthcare network by providing timely and accurate diagnostic information to clinicians and hospitals.
Address: Building 2, Darwin Corporate Park, 631 Stuart Highway, Berrimah, NT 0828
Crucial for delivering diagnostic services across the Northern Territory, including to remote Indigenous communities and regional health services.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Australian Clinical Labs' leadership includes:
Australian Clinical Labs has been backed by several prominent investors over the years, including:
Based on publicly available information and recent company announcements, there have been no major C-suite (CEO, CFO, COO) departures or new hires publicly announced for Australian Clinical Labs in the last 12 months from March 2023 to March 2024. The core executive leadership team has remained stable.
Discover the tools Australian Clinical Labs uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Australian Clinical Labs commonly uses the email format combining the employee's first name and last name, separated by a dot, followed by '@clinicallabs.com.au'. Variations might exist for specific roles or departments.
[first].[last]@clinicallabs.com.au
Format
jane.doe@clinicallabs.com.au
Example
85%
Success rate
ASX Announcements • February 27, 2024
Australian Clinical Labs (ASX: ACL) released its financial results for the half-year ending December 31, 2023. The report detailed revenue of $328.7 million and highlighted performance amidst a challenging market, including the impact of collector EBA increases and lower COVID-19 testing volumes....more
ASX Announcements • August 23, 2023
ACL announced its full-year results for FY23, reporting on revenue, earnings, and strategic initiatives. The company noted the continued normalization of non-COVID pathology testing and ongoing integration of acquired businesses....more
ASX Announcements • November 21, 2023
The Chair and CEO of Australian Clinical Labs addressed shareholders at the 2023 Annual General Meeting, providing an overview of the company's performance, market conditions, and strategic priorities for the upcoming year....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Australian Clinical Labs, are just a search away.